116 related articles for article (PubMed ID: 12095168)
1. Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator--yeast carboxymethyl glucan.
Kogan G; Sandula J; Korolenko TA; Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Kaledin VI
Int Immunopharmacol; 2002 May; 2(6):775-81. PubMed ID: 12095168
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Stimulator beta-(1-->3)-D-carboxymethylglucan improves the efficiency of chemotherapy of Lewis lung carcinoma.
Falameeva OV; Poteryaeva ON; Zhanaeva SY; Levina OA; Filatova TG; Korolenko TA; Kaledin VI; Sandula I; Kogan G
Bull Exp Biol Med; 2001 Aug; 132(2):787-90. PubMed ID: 11713568
[TBL] [Abstract][Full Text] [Related]
3. Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice.
Korolenko TA; Poteryaeva ON; Falameeva OV; Levina OA
Bull Exp Biol Med; 2003 Jul; 136(1):46-8. PubMed ID: 14534608
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a special combination of glucan with organic selenium derivative in different murine tumor models.
Vetvicka V; Pinatto-Botelho MF; Dos Santos AA; De Oliveira CA
Anticancer Res; 2014 Dec; 34(12):6939-44. PubMed ID: 25503119
[TBL] [Abstract][Full Text] [Related]
5. Soluble glucan protects against endotoxin shock in the rat: the role of the scavenger receptor.
Vereschagin EI; van Lambalgen AA; Dushkin MI; Schwartz YS; Polyakov L; Heemskerk A; Huisman E; Thijs LG; van den Bos GC
Shock; 1998 Mar; 9(3):193-8. PubMed ID: 9525326
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha 1-proteinase inhibitor in semisoluble glucan induced resistance to hemorrhage.
Vereschagin EI; Korolenko TA; Arkhipov SA
Agents Actions Suppl; 1992; 38 ( Pt 3)():385-8. PubMed ID: 1462871
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the novel chemically modified fungal polysaccharides as the macrophage stimulators.
Dergunova MA; Alexeenko TV; Zhanaeva SY; Filyushina EE; Buzueva II; Kolesnikova OP; Kogan G; Korolenko TA
Int Immunopharmacol; 2009 Jun; 9(6):729-33. PubMed ID: 19268718
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley.
Akramiene D; Grazeliene G; Didziapetriene J; Kevelaitis E
Medicina (Kaunas); 2009; 45(6):480-5. PubMed ID: 19605969
[TBL] [Abstract][Full Text] [Related]
10. Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis.
Chen C; Ju R; Shi J; Chen W; Sun F; Zhu L; Li J; Zhang D; Ye C; Guo L
J Pharmacol Exp Ther; 2017 Aug; 362(2):219-229. PubMed ID: 28515157
[TBL] [Abstract][Full Text] [Related]
11. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered beta-glucan in mice.
Suzuki I; Sakurai T; Hashimoto K; Oikawa S; Masuda A; Ohsawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1606-8. PubMed ID: 1934182
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice.
Usova TA; Poteryaeva ON; Zhanayeva SY; Yarygina ES; Korolenko TA
Bull Exp Biol Med; 2003 Jan; 135(1):81-4. PubMed ID: 12717521
[TBL] [Abstract][Full Text] [Related]
14. Effect of baikal skullcap extract administered alone or in combination with cyclophosphamide on natural cytotoxicity system in mice with Lewis lung carcinoma.
Kaplya OA; Sherstoboev EY; Zueva EP; Razina TG; Amosova EN; Krylova SG
Bull Exp Biol Med; 2004 May; 137(5):471-4. PubMed ID: 15455121
[TBL] [Abstract][Full Text] [Related]
15. The effect of two glucan carboxymethyl derivatives with various substitution degrees on cyclophosphamide immunosuppression in mice.
Wagnerová J; Lísková A; Navarová J; Kristofová A; Trnovec T; Ferencík M
Immunopharmacol Immunotoxicol; 1993; 15(2-3):227-42. PubMed ID: 8349950
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
17. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
[TBL] [Abstract][Full Text] [Related]
18. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
Sakurai T; Ohno N; Suzuki I; Yadomae T
Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
